In this week’s patent news: Patent Office notifies Supreme Court’s order on Extensions of Timelines; Patent office announces JPO/IPR Training Course FY 2021; BananaIP and...
Read more about Natco withdraws compulsory license, signs agreement with Eli Lilly for Barcitinib; Patent Office notifies extension of timelines and moreTag: Eli Lilly
Innovate, Patent, Produce and Prosper says PM, Natco Pharma faces patent infringement law suit and more
In this week’s Patent & Design News - “Innovate, Patent, Produce and Prosper,” says PM Narendra Modi; 12th edition of GIPC to be held in...
Read more about Innovate, Patent, Produce and Prosper says PM, Natco Pharma faces patent infringement law suit and morePatent Infringement Claim on Cancer Treatment Drug
The UK Court of Appeal ruled that Actavis’s alternative salt forms of pemetrexed would indirectly infringe Eli Lilly’s cancer drug patent. The decision provides insights into patent claim construction and the approach to pharmaceutical patent disputes across multiple European jurisdictions.
Read more about Patent Infringement Claim on Cancer Treatment Drug